Analyst Upgrades and Downgrades - Barclays analyst Eddie Kim upgraded Helmerich & Payne, Inc. from Equal-Weight to Overweight, raising the price target from $17 to $25, with shares closing at $20.54 [3] - UBS analyst Alex Kramm upgraded FactSet Research Systems Inc. from Neutral to Buy but lowered the price target from $480 to $425, with shares closing at $289.15 [3] - BMO Capital analyst Kostas Biliouris upgraded Sarepta Therapeutics, Inc. from Market Perform to Outperform, maintaining the price target at $50, with shares closing at $17.43 [3] - Evercore ISI Group analyst Daniel Markowitz upgraded Repligen Corporation from In-Line to Outperform, raising the price target from $130 to $155, with shares closing at $122.30 [3] - Wells Fargo analyst Zachary Fadem upgraded Brinker International, Inc. from Equal-Weight to Overweight, boosting the price target from $165 to $175, with shares closing at $136.35 [3]

Group 1 - Truist Securities upgraded Bill.com Holdings Inc. from Hold to Buy and raised its price target to $63 from $50, resulting in a share price increase of over 1% [1] - The bullish stance is based on three factors: potential upside to Street revenue forecasts, optionality from activist involvement by Elliott Management and Starboard Value, and expectations for a rebound in sentiment as estimates have bottomed [1] - Bill.com has been the worst-performing stock in its coverage group this year, indicating potential for a "catch-up trade" [2]

Core Viewpoint - BILL Holdings Inc has received an upgrade from Truist Securities to "buy" with a price target increase to $63 from $50, indicating potential growth driven by new activist shareholders [1] Group 1: Analyst Ratings and Upgrades - Truist Securities upgraded BILL from "hold" to "buy," raising the price target to $63 from $50 [1] - Wolfe Research also upgraded BILL to "outperform" just over a week prior [1] - Despite recent upgrades, 12 out of 26 analysts still maintain a "hold" rating on the stock, suggesting further potential for upgrades [1] Group 2: Stock Performance and Market Sentiment - BILL's stock broke out of a range below $49 earlier this month and is on track for its third consecutive daily gain [2] - The stock is down 37.4% year to date, indicating it has not yet recovered from a significant bear gap in February [2] - Short interest in BILL has increased, now representing 11% of the stock's available float, which could provide upward momentum [2] Group 3: Options Market Insights - The Schaeffer's Volatility Index (SVI) for BILL is at 42%, ranking in the 5th percentile of its annual range, suggesting that options traders are anticipating low volatility [3]

Group 1 - Lennar is expected to report a 49% decline in Q3 earnings to $2.10 per share, with revenue decreasing by 5% [1] - Investor sentiment is focused on the potential revival of housing demand due to falling interest rates [1] - Millrose Properties has been established as a spinout, with many homebuilders trading near buy points following the recent Fed rate cut [2] Group 2 - The upcoming Fed meeting is anticipated to impact major companies including FedEx, Lennar, and Meta [4] - DR Horton has shown improved technical strength, clearing a technical benchmark with an 80-plus Relative Strength Rating [4] - Millrose Properties Class A has also reached an 80-plus Relative Strength Rating benchmark, indicating strong market performance [4]

Analyst Upgrades and Price Targets - Needham analyst Gil Blum upgraded Amicus Therapeutics, Inc. (FOLD) from Hold to Buy with a price target of $14, while shares closed at $7.97 [5] - RBC Capital analyst Walter Spracklin upgraded CSX Corporation (CSX) from Sector Perform to Outperform, raising the price target from $37 to $39, with shares closing at $32.77 [5] - Scotiabank analyst Alfonso Salazar upgraded Vale S.A. (VALE) from Sector Perform to Sector Outperform, setting a price target of $14, with shares closing at $10.88 [5] - RBC Capital analyst Piral Dadhania upgraded NIKE, Inc. (NKE) from Sector Perform to Outperform, increasing the price target from $76 to $90, while shares closed at $72.31 [5] - JP Morgan analyst Lisa Gill upgraded Aveanna Healthcare Holdings Inc. (AVAH) from Underweight to Neutral, raising the price target from $6 to $10, with shares closing at $8.08 [5]

Core Viewpoint - Chewy (CHWY) received two analyst upgrades, resulting in a nearly 3% increase in its share price, outperforming the S&P 500's 0.9% rise [1] Analyst Upgrades - Seaport Global Securities's Aaron Kessler upgraded Chewy's recommendation to buy from neutral, setting a price target of $47 per share, which is 30% above the recent closing price [2] - Deutsche Bank's Leo Horowitz also upgraded Chewy to buy from neutral, raising his price target to $45 per share from $38 [6] Financial Performance - Chewy reported a strong year-over-year revenue growth of nearly 9% alongside robust gross margins [4] - Despite the positive financial performance, the market reacted negatively due to increased selling, general, and administrative costs, as well as anticipated higher investments in the second half of the year [5] Strategic Investments - Kessler believes the negative market reaction is unjustified and views the anticipated investments as strategic, which should enhance the company's fundamentals [5] - Horowitz highlighted appealing initiatives such as the Chewy+ Membership program as potential growth drivers for the company [6]

Group 1 - Citigroup upgraded Oracle Corporation's rating from Neutral to Buy [1] - The target price for Oracle was raised from $240 to $410 [1] - Previously, on September 9, Citigroup had increased Oracle's target price from $196 to $240 [1]

康宁(GLW.US)一度涨超2%，最高触及68.58美元。消息面上，瑞银将康宁的目标价从65美元上调至84美 元，评级从"中性"上调至"买入"。(格隆汇) ...

Group 1 - The stock price of Sankeshu is reported at 49.11 yuan as of August 26, 2025, with a decrease of 1.90 yuan, representing a decline of 3.72% from the previous trading day [1] - The opening price for the day was 51.00 yuan, with a highest point of 51.02 yuan and a lowest point of 48.29 yuan, and the trading volume reached 68,155 hands with a transaction amount of 335 million yuan [1] - Sankeshu operates in the decoration and building materials industry, focusing on the research, production, and sales of architectural coatings, and is recognized as a leading domestic paint enterprise [1] Group 2 - The product range of Sankeshu includes wall coatings, wood coatings, and adhesives, which are widely used in real estate and home decoration sectors [1] - Recently, Founder Securities upgraded Sankeshu's rating from "Recommended" to "Strongly Recommended," indicating a positive outlook from institutions regarding the company's development prospects [1] - On August 26, the net inflow of main funds into Sankeshu was 3.4795 million yuan, with a cumulative net inflow of 37.893 million yuan over the past five trading days [1]

Group 1 - Venture Global, a natural gas supplier, saw its stock rise over 3% in pre-market trading on August 25 [1] - UBS upgraded Venture Global's rating from "Neutral" to "Buy" [1]